These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
232 related items for PubMed ID: 31593217
1. Development and Application of a Life-Stage Physiologically Based Pharmacokinetic (PBPK) Model to the Assessment of Internal Dose of Pyrethroids in Humans. Mallick P, Moreau M, Song G, Efremenko AY, Pendse SN, Creek MR, Osimitz TG, Hines RN, Hinderliter P, Clewell HJ, Lake BG, Yoon M. Toxicol Sci; 2020 Jan 01; 173(1):86-99. PubMed ID: 31593217 [Abstract] [Full Text] [Related]
2. Evaluation of Age-Related Pyrethroid Pharmacokinetic Differences in Rats: Physiologically-Based Pharmacokinetic Model Development Using In Vitro Data and In Vitro to In Vivo Extrapolation. Song G, Moreau M, Efremenko A, Lake BG, Wu H, Bruckner JV, White CA, Osimitz TG, Creek MR, Hinderliter PM, Clewell HJ, Yoon M. Toxicol Sci; 2019 Jun 01; 169(2):365-379. PubMed ID: 30768128 [Abstract] [Full Text] [Related]
4. Metabolism of bifenthrin, β-cyfluthrin, λ-cyhalothrin, cyphenothrin and esfenvalerate by rat and human cytochrome P450 and carboxylesterase enzymes. Hedges L, Brown S, MacLeod AK, Moreau M, Yoon M, Creek MR, Osimitz TG, Lake BG. Xenobiotica; 2020 Dec 01; 50(12):1434-1442. PubMed ID: 32672501 [Abstract] [Full Text] [Related]
6. Metabolism of deltamethrin and cis- and trans-permethrin by rat and human liver microsomes, liver cytosol and plasma preparations. Hedges L, Brown S, Vardy A, Doyle E, Yoon M, Osimitz TG, Lake BG. Xenobiotica; 2019 Apr 01; 49(4):388-396. PubMed ID: 29537356 [Abstract] [Full Text] [Related]
9. In vitro metabolism of pyrethroid pesticides by rat and human hepatic microsomes and cytochrome p450 isoforms. Scollon EJ, Starr JM, Godin SJ, DeVito MJ, Hughes MF. Drug Metab Dispos; 2009 Jan 01; 37(1):221-8. PubMed ID: 18948380 [Abstract] [Full Text] [Related]
12. Identification of rat and human cytochrome p450 isoforms and a rat serum esterase that metabolize the pyrethroid insecticides deltamethrin and esfenvalerate. Godin SJ, Crow JA, Scollon EJ, Hughes MF, DeVito MJ, Ross MK. Drug Metab Dispos; 2007 Sep 01; 35(9):1664-71. PubMed ID: 17576809 [Abstract] [Full Text] [Related]
13. PBPK modeling to support risk assessment of pyrethroid exposure in French pregnant women. Thépaut E, Bisson M, Brochot C, Personne S, Appenzeller BMR, Zaros C, Chardon K, Zeman F. Environ Res; 2024 Jun 15; 251(Pt 1):118606. PubMed ID: 38460660 [Abstract] [Full Text] [Related]
14. Species differences in the in vitro metabolism of deltamethrin and esfenvalerate: differential oxidative and hydrolytic metabolism by humans and rats. Godin SJ, Scollon EJ, Hughes MF, Potter PM, DeVito MJ, Ross MK. Drug Metab Dispos; 2006 Oct 15; 34(10):1764-71. PubMed ID: 16855054 [Abstract] [Full Text] [Related]
16. Environmentally relevant mixing ratios in cumulative assessments: a study of the kinetics of pyrethroids and their ester cleavage metabolites in blood and brain; and the effect of a pyrethroid mixture on the motor activity of rats. Starr JM, Graham SE, Ross DG, Tornero-Velez R, Scollon EJ, Devito MJ, Crofton KM, Wolansky MJ, Hughes MF. Toxicology; 2014 Jun 05; 320():15-24. PubMed ID: 24631210 [Abstract] [Full Text] [Related]
17. Lack of P-glycoprotein-mediated efflux and the potential involvement of an influx transport process contributing to the intestinal uptake of deltamethrin, cis-permethrin, and trans-permethrin. Zastre J, Dowd C, Bruckner J, Popovici A. Toxicol Sci; 2013 Dec 05; 136(2):284-93. PubMed ID: 24014652 [Abstract] [Full Text] [Related]
19. Environmentally relevant mixtures in cumulative assessments: an acute study of toxicokinetics and effects on motor activity in rats exposed to a mixture of pyrethroids. Starr JM, Scollon EJ, Hughes MF, Ross DG, Graham SE, Crofton KM, Wolansky MJ, Devito MJ, Tornero-Velez R. Toxicol Sci; 2012 Dec 05; 130(2):309-18. PubMed ID: 22872056 [Abstract] [Full Text] [Related]
20. Development of a Physiologically Based Pharmacokinetic Model for Sinogliatin, a First-in-Class Glucokinase Activator, by Integrating Allometric Scaling, In Vitro to In Vivo Exploration and Steady-State Concentration-Mean Residence Time Methods: Mechanistic Understanding of its Pharmacokinetics. Song L, Zhang Y, Jiang J, Ren S, Chen L, Liu D, Chen X, Hu P. Clin Pharmacokinet; 2018 Oct 05; 57(10):1307-1323. PubMed ID: 29626326 [Abstract] [Full Text] [Related] Page: [Next] [New Search]